Showing results (181-190 of 206) with videos related to
Sort By:
Pageof 21
Genes, Chromosomes & Cancer|June 12, 2014
Interstitial 13q14 deletions detected in the karyotype and translocations with concomitant deletion at 13q14 in chronic lymphocytic leukemia: different genetic mechanisms but equivalent poorer clinical outcomeAnna Puiggros, Marta Venturas, Marta Salido, et al.The Journal of Molecular Diagnostics : JMD|July 1, 2018
Multicenter Evaluation of the Idylla NRAS-BRAF Mutation Test in Metastatic Colorectal CancerIván Prieto-Potin, Clara Montagut, Beatriz Bellosillo, et al.European Journal of Haematology|December 4, 2020
The risk of thrombosis in essential thrombocythemia is associated with the type of CALR mutation: A multicentre collaborative studyManuel M Pérez Encinas, Marta Sobas, María Teresa Gómez-Casares, et al.Nature Medicine|June 2, 2015
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patientsGiulia Siravegna, Benedetta Mussolin, Michela Buscarino, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 5, 2022
Evaluating the Potential of Polygenic Risk Score to Improve Colorectal Cancer ScreeningCoral Arnau-Collell, Anna Díez-Villanueva, Beatriz Bellosillo, et al.JCO Precision Oncology|February 1, 2022
Clinical Impact of Circulating Tumor RAS and BRAF Mutation Dynamics in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy Plus Anti-Epidermal Growth Factor Receptor TherapyJoan Maurel, Vicente Alonso, Pilar Escudero, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2020
Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from ImmunotherapyCristina Carrato, Francesc Alameda, Anna Esteve-Codina, et al.British Journal of Haematology|August 4, 2020
Cytoreductive treatment in patients with CALR-mutated essential thrombocythaemia: a study comparing indications and efficacy among genotypes from the Spanish Registry of Essential ThrombocythaemiaAlberto Alvarez-Larrán, Anna Angona, Marcio Andrade-Campos, et al.Annals of Hematology|December 12, 2018
International external quality assurance of JAK2 V617F quantificationJulia Asp, Vibe Skov, Beatriz Bellosillo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2020
RNA sequencing and Immunohistochemistry Reveal ZFN7 as a Stronger Marker of Survival than Molecular Subtypes in G-CIMP-negative GlioblastomaAnna Esteve-Codina, Francesc Alameda, Cristina Carrato, et al.Pageof 21